Pesquisar
Pfizer Inc
PFEAdicionar à lista de desejos
24.480USD
+0.310+1.28%
Fechamento 07/13, 16:00（ET）Cotações atrasadas em 15 min
139.52BValor de mercado
18.59P/L TTM
Mais detalhes de Pfizer Inc Empresa
Pfizer Inc. is a research-based, global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. Its Biopharma segment includes the Pfizer U.S. Commercial Division, and the Pfizer International Commercial Division. Its product categories include oncology, primary care and specialty care. Its oncology products include Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak and Talzenna. Its primary care products include Eliquis, Nurtec ODT/Vydura, Zavzpret, the Prevnar family, Comirnaty, Abrysvo, FSME/IMMUN-TicoVac, Nimenrix, Trumenba, and Paxlovid. Its specialty care products include Xeljanz, Enbrel (outside the United States and Canada), Inflectra, Abrilada, Cibinqo, Litfulo, Eucrisa, Velsipity, the Vyndaqel family, Genotropin, BeneFIX, Xyntha, Somavert, Ngenla, Hympavzi, Sulperazon, Zavicefta, Octagam and others.
Informações de Pfizer Inc
Código da empresaPFE
Nome da EmpresaPfizer Inc
Data de listagemFeb 22, 2080
CEOBourla (Albert)
Número de funcionários81000
Tipo de títulosOrdinary Share
Fim do ano fiscalFeb 22
Endereço66 Hudson Boulevard East
CidadeNEW YORK
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal10001-2192
Telefone12127332323
Sitehttps://www.pfizer.com/
Código da empresaPFE
Data de listagemFeb 22, 2080
CEOBourla (Albert)
Executivos da empresa Pfizer Inc
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Albert Bourla, Ph.D.
Dr. Albert Bourla, Ph.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
394.63K
+4.08%
Mr. Douglas M. Lankler
Mr. Douglas M. Lankler
Executive Vice President, Chief Legal Officer
Executive Vice President, Chief Legal Officer
165.26K
+2.36%
Ms. Sally Susman
Ms. Sally Susman
Executive Vice President, Chief Corporate Affairs Officer
Executive Vice President, Chief Corporate Affairs Officer
95.94K
+7.61%
Mr. Michael (Ike) Mcdermott
Mr. Michael (Ike) Mcdermott
Executive Vice President, Chief Global Supply Officer
Executive Vice President, Chief Global Supply Officer
68.47K
-3.36%
Ms. Lidia L. Fonseca
Ms. Lidia L. Fonseca
Executive Vice President, Chief Digital and Technology Officer
Executive Vice President, Chief Digital and Technology Officer
32.73K
+5.39%
Mr. Ronald E. Blaylock
Mr. Ronald E. Blaylock
Independent Director
Independent Director
32.46K
--
Mr. Aamir Malik
Mr. Aamir Malik
Executive Vice President, Chief US Commercial Officer
Executive Vice President, Chief US Commercial Officer
29.55K
--
Ms. Payal Sahni
Ms. Payal Sahni
Executive Vice President, Chief People Experience Officer
Executive Vice President, Chief People Experience Officer
26.59K
+6.54%
Dr. Scott Gottlieb, M.D.
Dr. Scott Gottlieb, M.D.
Independent Director
Independent Director
10.00K
--
Mr. Cyrus Taraporevala
Mr. Cyrus Taraporevala
Independent Director
Independent Director
10.00K
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Albert Bourla, Ph.D.
Dr. Albert Bourla, Ph.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
394.63K
+4.08%
Mr. Douglas M. Lankler
Mr. Douglas M. Lankler
Executive Vice President, Chief Legal Officer
Executive Vice President, Chief Legal Officer
165.26K
+2.36%
Ms. Sally Susman
Ms. Sally Susman
Executive Vice President, Chief Corporate Affairs Officer
Executive Vice President, Chief Corporate Affairs Officer
95.94K
+7.61%
Mr. Michael (Ike) Mcdermott
Mr. Michael (Ike) Mcdermott
Executive Vice President, Chief Global Supply Officer
Executive Vice President, Chief Global Supply Officer
68.47K
-3.36%
Ms. Lidia L. Fonseca
Ms. Lidia L. Fonseca
Executive Vice President, Chief Digital and Technology Officer
Executive Vice President, Chief Digital and Technology Officer
32.73K
+5.39%
Mr. Ronald E. Blaylock
Mr. Ronald E. Blaylock
Independent Director
Independent Director
32.46K
--
Perguntas frequentes
Quem são os cinco principais acionistas de Pfizer Inc?
Os cinco principais acionistas de Pfizer Inc são: Dr. Albert Bourla, Ph.D.
Quantas instituições possuem ações da Pfizer Inc (PFE)?
Em 2026Q1, 4824 instituições possuíam ações da Pfizer Inc, com valor de mercado aproximado de 3.98B, representando 69.87% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em 29483336.00.
Qual é a maior fonte de receita da Pfizer Inc?
Em 2026Q1, o segmento de negócios Eliquis alliance revenues and direct sales gerou a maior receita para Pfizer Inc, totalizando 7.96B e representando 12.72% da receita total.